Latest Breaking News On - Soleno therapeutics - Page 9 : comparemela.com

Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) CEO Bhatnagar Anish sold 2,527 shares of Soleno Therapeutics stock in a transaction that occurred on Thursday, January 25th. The shares were sold at an average price of $48.30, for a total value of $122,054.10. Following the completion of the transaction, the chief executive officer now owns […]

Bhatnagar anishStifel nicolausSoleno therapeutics incCarlyle group incSecurities exchange commissionEmerald mutual fund advisersPerceptive advisorsSchonfeld strategic advisorsEmerald advisersSoleno therapeuticsGet free reportExchange commissionMutual fund advisers trustDiazoxide choline extended releaseSoleno therapeutics dailyNasdaq slno